Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC470914350;14351;14352 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
N2AB439213399;13400;13401 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
N2A346510618;10619;10620 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
N2B434613261;13262;13263 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
Novex-1447113636;13637;13638 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
Novex-2453813837;13838;13839 chr2:178738328;178738327;178738326chr2:179603055;179603054;179603053
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTG
  • RefSeq wild type template codon: GAC
  • Domain: Ig-30
  • Domain position: 10
  • Structural Position: 13
  • Q(SASA): 0.3299
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P rs756566095 -1.035 0.971 D 0.72 0.548 0.731923157262 gnomAD-2.1.1 4.03E-06 None None None None I None 0 0 None 0 5.61E-05 None 0 None 0 0 0
L/P rs756566095 -1.035 0.971 D 0.72 0.548 0.731923157262 gnomAD-4.0.0 1.59303E-06 None None None None I None 0 0 None 0 2.78149E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.2033 likely_benign 0.2637 benign -1.474 Destabilizing 0.754 D 0.44 neutral None None None None I
L/C 0.5672 likely_pathogenic 0.6248 pathogenic -0.909 Destabilizing 0.998 D 0.615 neutral None None None None I
L/D 0.8175 likely_pathogenic 0.8693 pathogenic -0.392 Destabilizing 0.956 D 0.711 prob.delet. None None None None I
L/E 0.2663 likely_benign 0.3527 ambiguous -0.325 Destabilizing 0.754 D 0.624 neutral None None None None I
L/F 0.2419 likely_benign 0.2657 benign -0.818 Destabilizing 0.993 D 0.56 neutral None None None None I
L/G 0.6314 likely_pathogenic 0.7431 pathogenic -1.855 Destabilizing 0.956 D 0.699 prob.neutral None None None None I
L/H 0.3136 likely_benign 0.3741 ambiguous -1.084 Destabilizing 0.994 D 0.698 prob.neutral None None None None I
L/I 0.0875 likely_benign 0.085 benign -0.485 Destabilizing 0.926 D 0.406 neutral None None None None I
L/K 0.225 likely_benign 0.2733 benign -0.816 Destabilizing 0.915 D 0.585 neutral None None None None I
L/M 0.0986 likely_benign 0.1064 benign -0.501 Destabilizing 0.971 D 0.581 neutral N 0.50672811 None None I
L/N 0.5502 ambiguous 0.623 pathogenic -0.721 Destabilizing 0.956 D 0.718 prob.delet. None None None None I
L/P 0.9263 likely_pathogenic 0.9523 pathogenic -0.784 Destabilizing 0.971 D 0.72 prob.delet. D 0.545039717 None None I
L/Q 0.0938 likely_benign 0.1374 benign -0.754 Destabilizing 0.058 N 0.341 neutral N 0.494212521 None None I
L/R 0.1759 likely_benign 0.2301 benign -0.465 Destabilizing 0.89 D 0.664 neutral N 0.518002921 None None I
L/S 0.277 likely_benign 0.3684 ambiguous -1.466 Destabilizing 0.915 D 0.585 neutral None None None None I
L/T 0.1611 likely_benign 0.1968 benign -1.265 Destabilizing 0.956 D 0.597 neutral None None None None I
L/V 0.0715 likely_benign 0.0749 benign -0.784 Destabilizing 0.822 D 0.353 neutral N 0.458740583 None None I
L/W 0.4041 ambiguous 0.4631 ambiguous -0.929 Destabilizing 0.998 D 0.675 prob.neutral None None None None I
L/Y 0.5378 ambiguous 0.5695 pathogenic -0.66 Destabilizing 0.978 D 0.657 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.